In this episode of The Deep Dive, supported by RevGenetics, we explore a groundbreaking advancement in cellular rejuvenation and stem cell therapy. As we age, our body's mesenchymal stromal cells (MSCs) enter cellular senescence—changing shape and effectively pulling the emergency brake on cell division via proteins like P16 and P21. However, a landmark new study reveals a way to reset these aging stem cells, stripping away cellular damage so they can divide, function, and repair tissue like young cells again. Could reversing MSC senescence transform the future of tissue repair, longevity, and stem cell medicine? Join Les and Amy as they unpack the mechanisms behind this breakthrough and what it means for the future of anti-aging science.

Supported by RevGenetics – Science-Based Supplements For Healthy Aging
👉 Explore Longevity Products

Referenced Study:
🔗 Rapamycin and nicotinamide treatment attenuates senescence-associated features in mesenchymal stromal cells isolated from elderly donors by modulating autophagy

Hashtags:
#StemCells #LongevityResearch #CellularRejuvenation #HealthyAging #StemCellTherapy #AntiAgingMedicine #RevGenetics #MSCs #DeepDivePodcast #CellularSenescence #ScienceBreakthroughs #TissueRepair #Autophagy #Rapamycin #Nicotinamide #P16P21 #LongevityPotential #AntiAgingBreakthrough #RevGeneticsSupport

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör RevGenetics. Innehållet i podden är skapat av RevGenetics och inte av, eller tillsammans med, Poddtoppen.